FDA clears Corgenix' tests for thrombosis risk:
This article was originally published in Clinica
Executive Summary
Corgenix Medical's IgG anti-Prothrombin and IgM anti-Prothrombin antibody test kits are for the diagnosis and risk assessment of certain cardiovascular disorders characterised by blood clot formation. The tests will be added to the Denver, Colorado company's range of ELISA-based diagnostic assays for antiphospholipid antibodies.